| Plavix 300 mg film-coated tablets EU/1/98/069/008-010 |
Clopidogrel hydrogensulfate |
Sanofi Winthrop Industrie |
— |
| Plavix 75 mg film-coated tablets EU/1/98/069/001-007 |
Clopidogrel hydrogensulfate |
Sanofi Winthrop Industrie |
— |
| Quadrivalent Influenza Vaccine (split virion, inactivated), suspension for injection in pre-filled syringe Quadrivalent influenza vaccine (split virion, inactivated) PA23458/010/001 |
A/Victoria/4897/2022 (H1N1)pdm09-like strain (A/Victoria/4897/2022, IVR-238, B/Austria/1359417/2021 - like strain (B/Michigan/01/2021, wild type), B/PHUKET/3073/2013 -LIKE STRAIN (B/PHUKET/3073/2013, WILD TYPE), Influenza A virus, A/Croatia/10136RV/2023 (H3N2) like strain X-425A, Inactivated |
Sanofi Winthrop Industrie |
Not marketed |
| Renagel EU/1/99/123/006 |
Sevelamer |
Sanofi Winthrop Industrie |
— |
| Renagel EU/1/99/123/007 |
Sevelamer |
Sanofi Winthrop Industrie |
— |
| Renagel EU/1/99/123/009 |
Sevelamer |
Sanofi Winthrop Industrie |
— |
| Renagel EU/1/99/123/010 |
Sevelamer |
Sanofi Winthrop Industrie |
— |
| Renagel EU/1/99/123/011-013 |
Sevelamer |
Sanofi Winthrop Industrie |
— |
| Renagel 400 mg Film-coated tablet EU/1/99/123/005-007 |
Sevelamer |
Sanofi Winthrop Industrie |
— |
| Renagel 800 mg Film-coated tablet EU/1/99/123/008-013 |
Sevelamer |
Sanofi Winthrop Industrie |
— |
| Renvela 0.8 g Powder for oral suspension EU/1/09/521/008-009 |
Sevelamer carbonate |
Sanofi Winthrop Industrie |
— |
| Renvela 0.8 g Powder for oral suspension (with dosing spoon) EU/1/09/521/009 |
Sevelamer carbonate |
Sanofi Winthrop Industrie |
— |
| Renvela 1.6 g Powder for oral suspension EU/1/09/521/4-5 |
Sevelamer carbonate |
Sanofi Winthrop Industrie |
— |
| Renvela 2.4 g Powder for oral suspension EU/1/09/521/6-7 |
Sevelamer carbonate |
Sanofi Winthrop Industrie |
— |
| Renvela 800 mg Film-coated tablet EU/1/09/521/1-3 |
Sevelamer carbonate |
Sanofi Winthrop Industrie |
— |
| REPEVAX, suspension for injection, in pre-filled syringe Diphtheria, Tetanus, Pertussis (acellular, component) and Poliomyelitis (inactivated) Vaccine (adsorbed, reduced antigen(s) content) PA23458/004/001 |
Tetanus toxoid, Diphtheria toxoid, Pertussis toxoid, Filamentous haemagglutinin, Pertactin |
Sanofi Winthrop Industrie |
Not marketed |
| REVAXIS Suspension for injection in pre-filled syringe Diphtheria, tetanus and poliomyelitis (inactivated) vaccine (adsorbed, reduced antigen(s) content) PA23458/005/001 |
Diphtheria toxoid, Tetanus toxoid, POLIOVIRUS, TYPE 1, Poliovirus, type 2, Poliovirus, type 3 |
Sanofi Winthrop Industrie |
Marketed |
| RILUTEK 50 mg film-coated tablets EU/1/96/010/001 |
Riluzole |
Sanofi Winthrop Industrie |
— |
| SARCLISA 20 mg/mL concentrate for solution for infusion EU/1/20/1435/001-003 |
Isatuximab |
Sanofi Winthrop Industrie |
— |
| Sevelamer carbonate Winthrop 0.8 g powder for oral suspension EU/1/14/952/005-006 |
Sevelamer carbonate |
Sanofi Winthrop Industrie |
— |
| Sevelamer carbonate Winthrop 2.4 g powder for oral suspension EU/1/14/952/002-003 |
Sevelamer carbonate |
Sanofi Winthrop Industrie |
— |
| Sevelamer carbonate Winthrop 800 mg film-coated tablets EU/1/14/952/001 |
Sevelamer carbonate, Sevelamer carbonate |
Sanofi Winthrop Industrie |
— |
| STAMARIL, powder and solvent for suspension for injection in pre-filled syringe. Yellow fever vaccine (Live) PA23458/006/001 |
Yellow fever virus 17 d-204 strain |
Sanofi Winthrop Industrie |
Marketed |
| Supemtek Tetra solution for injection in pre-filled syringe EU/1/20/1484/001-006 |
A/(H1N1)-LIKE VIRUS ANTIGEN |
Sanofi Winthrop Industrie |
— |
| Taxotere 20 mg/0.5 ml Concentrate and solvent for solution for infusion EU/1/95/002/001 |
Docetaxel trihydrate |
Sanofi Winthrop Industrie |
— |
| Taxotere 20 mg/1 ml Concentrate and solvent for solution for infusion EU/1/95/002/003 |
Docetaxel trihydrate |
Sanofi Winthrop Industrie |
— |
| Taxotere 80 mg/2 ml Concentrate and solvent for solution for infusion EU/1/95/002/002 |
Docetaxel trihydrate |
Sanofi Winthrop Industrie |
— |
| Taxotere 80 mg/4 ml Concentrate and solvent for solution for infusion EU/1/95/002/004 |
Docetaxel trihydrate |
Sanofi Winthrop Industrie |
— |
| Tetravac, suspension for injection in prefilled syringe Diphtheria, tetanus, pertussis (acellular, component) and poliomyelitis (inactivated) vaccine, (adsorbed). PA23458/007/001 |
Adsorbed purified pertussis toxoid, Adsorbed purified filamentous haemagglutinin, Purified tetanus toxoid, Purified diphtheria toxoid ph. eur., Inactivated type 1 poliovirus |
Sanofi Winthrop Industrie |
Marketed |
| Thyrogen 0.9 mg Powder for solution for injection EU/1/99/122/001 |
Thyrotropin alfa |
Sanofi Winthrop Industrie |
— |
| Thyrogen 0.9 mg Powder for solution for injection EU/1/99/122/002 |
Thyrotropin alfa |
Sanofi Winthrop Industrie |
— |
| Triaxis, suspension for injection in a pre-filled syringe Diphtheria, Tetanus, Pertussis (acellular component) Vaccine (adsorbed, reduced antigen(s) content) PA23458/008/001 |
Diphtheria toxoid, Tetanus toxoid, Pertussis toxoid, Filamentous haemagglutinin, Pertactin (prn) |
Sanofi Winthrop Industrie |
Not marketed |
| Truvelog Mix 30 EU/1/22/1639/001-005 |
Insulin aspart |
Sanofi Winthrop Industrie |
— |
| Typhim Vi Solution for Injection Typhoid Polysaccharide Vaccine PA23458/009/001 |
Salmonella typhi, vi antigen |
Sanofi Winthrop Industrie |
Marketed |
| Vaxigrip suspension for injection in pre-filled syringe.Trivalent influenza vaccine (split virion, inactivated). PA23458/002/001 |
Influenza Inactivated Split Virus Strain A (H1N1), Influenza Inactivated Split Virus Strain A (H3N2), Influenza Inactivated Split Virus Strain B |
Sanofi Winthrop Industrie |
Marketed |
| Verorab, powder and solvent for suspension for injection. Rabies vaccine, inactivated. PA23458/011/001 |
Rabies virus (inactivated) strain wistar (PM/WI 38-1503-3M) |
Sanofi Winthrop Industrie |
Marketed |
| ZALTRAP 25 mg/ml concentrate for solution for infusion EU/1/12/814/001-003 |
Aflibercept |
Sanofi Winthrop Industrie |
— |